Bioengineered Smart Nanocarriers for Breast Cancer Treatment: Adorned Carbon-Based Nanocomposites with Silver and Palladium Complexes for Efficient Drug Delivery.

Biocompatible and bioactive carbon-based nanocomposites are ingeniously designed and fabricated with the aim of enhancing drug delivery applicability in breast cancer treatment. Reduced graphene oxide (rGO) and multiwalled carbon nanotubes (MWCNTs) are utilized as nanocarriers for increasing penetrability into cells and the loading capacity. What sets our study apart is the strategic incorporation of the two different complexes of silver (AgL2) and palladium (PdL2) with the carboxamide-based ligand C9H7N3OS (L), which have been synthesized and decorated on nanocarriers alongside doxorubicin (DOX) for stabilizing DOX by π-π interactions and hydrogen bonding. Although DOX is a well-known cancer therapy agent, the efficacy of DOX is hindered owing to drug resistance, poor internalization, and limited site specificity. Aside from stabilizing DOX on nanocarriers, our carbon-based nanocarriers are tailored to act as a precision-guided missile, strategically by adorning with target-sensitive complexes. Based on the literature, carboxamide ligands can connect to overexpressed receptors on cancerous cells and inhibit them from proliferation signaling. Also, the complexes have an antibacterial activity that can control the infection caused by decreasing white blood cells and necrosis of cancerous cells. A high-concentration cytotoxicity assay revealed that decorating PdL2 on a DOX-containing nanocarrier not only increased cytotoxicity to breast cancerous cell lines (MDA-MB-231 and MCF-7) but also revealed higher cell viability on a normal cell line (MCF-10A). The drug release screening results showed that the presence of PdL2 led to 72 h correlate release behavior in acidic and physiological pH profiles, while the AgL2-containing nanocomposite showed an analogue behavior for just 6 h and the release of DOX continued and after about 100 h hit the top.

Green approach for the fabrication of dual-functional S/N doped graphene tagged ZnO nanograins for in vitro bioimaging and water pollutant remediation.

Dual-functional S/N (sulfur and nitrogen) doped graphene-tagged zinc oxide nanograins were synthesized for bioimaging applications and light-dependent photocatalytic activity. Applying the green synthesis approach, graphene was synthesized from kimchi cabbage through a hydrothermal process followed by tagging it with synthesized zinc oxide nanoparticles (ZnO-NPs). The 2D/0D heterostructure prepared by combining both exhibited exceptional advantages. Comprehensive characterizations such as TEM, SEM, XRD, FTIR, XPS, and UV-Vis spectra have been performed to confirm the structures and explore the properties of the synthesized nanocomposite. The graphene/ZnO-NP composite produced exhibited more intense fluorescence, greater chemical stability and biocompatibility, lower cytotoxicity, and better durability than ZnO NPs conferring them with potential applications in cellular imaging. While tagging the ZnO NPs with carbon derived from a natural source containing hydroxyl, sulfur, and nitrogen-containing functional group, the S/N doped graphene/ZnO heterostructure evidences the high photocatalytic activity under UV and visible irradiation which is 3.2 and 3.8 times higher than the as-prepared ZnO-NPs. It also demonstrated significant antibacterial activity which confers its application in removing pathogenic contaminant bacteria in water bodies. In addition, the composite had better optical properties and biocompatibility, and lower toxicity than ZnO NPs. Our findings indicate that the synthesized nanocomposite will be suitable for various biomedical and pollutant remediation due to its bright light-emitting properties and stable fluorescence.

The potential role of formononetin in cancer treatment: An updated review.

Currently, cancer is one of the main research topics, due to its high incidence and drug resistance to existing anti-cancer drugs. Formononetin, a natural product with phytoestrogenic properties and diverse biological functions, has attracted the attention of researchers working on anticancer drugs. Formononetin emerges as an intriguing bioactive substance compared to other isoflavones as it exhibits potent chemotherapeutic activity with less toxicity. Formononetin effectively plays a significant role in inhibiting cell proliferation, invasion, and metastatic abilities of cancer cells by targeting major signaling pathways at the junction of interconnected pathways. It also induces apoptosis and cell cycle arrest by modulating mediator proteins. It causes upregulation of key factors such as p-AKT, p38, p21, and p53 and downregulation of NF-κB. Furthermore, formononetin regulates the neoplastic microenvironment by inactivating the ERK1/2 pathway and lamin A/C signaling and has been reported to inactivate JAK/STAT, PKB or AKT, and mitogen-activated protein kinase pathways and to suppress cell migration, invasion, and angiogenesis in human cancer cells. To assist researchers in further exploring formononetin as a potential anticancer therapeutic candidate, this review focuses on both in vitro and in vivo proof of concept studies, patents, and clinical trials pertinent to formononetin's anticancer properties. Overall, this review discusses formononetin from a comprehensive perspective to highlight its potential benefits as an anticancer agent.

WS2-intercalated Ti3C2Tx MXene/TiO2-stacked hybrid structure as an excellent sonophotocatalyst for tetracycline degradation and nitrogen fixation.

Designing a heterostructure nanoscale catalytic site to facilitate N2 adsorption and photogenerated electron transfer would maximize the potential for photocatalytic activity and N2 reduction reactions. Herein, we have explored the interfacial TiO2 nanograins between the Ti3C2TxMXene-WS2 heterostructure and addressed the beneficial active sites to expand the effective charge transfer rate and promote sonophotocatalytic N2 fixation. Benefiting from the interfacial contact and dual heterostructure interface maximizes the photogenerated carrier separation between WS2 and MXene/TiO2. The sonophotocatalytic activity of the MXene@TiO2/WS2 hybrid, which was assessed by examining the photoreduction of N2 with ultrasonic irradiation, was much higher than that of either sonocatalytic and photocatalytic activity because of the synergistic sonocatalytic effect under photoirradiation. The Schottky junction between the MXene and TiO2 on the hybrid MXene/TiO2-WS2 heterostructure resulted in the sonophotocatalytic performance through effective charge transfer, which is 1.47 and 1.24 times greater than MXene-WS2 for nitrogen fixation and pollutant degradation, respectively. Under the sonophotocatalytic process, the MXene/TiO2-WS2 heterostructure exhibits a decomposition efficiency of 98.9 % over tetracycline in 90 min, which is 5.46, 1.73, and 1.10 times greater than those of sonolysis, sonocatalysis, and photocatalysis, respectively. The production rate of NH3 on MXene/TiO2-WS2 reached 526 µmol g-1h-1, which is 3.17, 3.61, and 1.47 times higher than that of MXene, WS2, and MXene-WS2, respectively. The hybridized structure of MXene-WS2 with interfacial surface oxidized TiO2 nanograins minimizes the band potential and improves photocarrier use efficiency, contributing directly to the remarkable catalytic performance towards N2 photo fixation under visible irradiation under ultrasonic irradiation. This report provides the strategic outcome for the mass carrier transfer rate and reveals a high conversion efficiency in the hybridized heterostructure.

Synergistic effects of layered Ti3C2TX MXene/MIL-101(Cr) heterostructure as a sonocatalyst for efficient degradation of sulfadiazine and acetaminophen in water.

In this work, different mass loadings of MXene-coupled MIL-101(Cr) (MXe/MIL-101(Cr)) nanocomposites were generated through a hydrothermal process in order to investigate the potential of this nanocomposite as a novel sonocatalyst for the elimination of sulfadiazine (SD) and acetaminophen (AAP) in aqueous media. The sonocatalytic activity of different MXe/MIL-101(Cr) compositions and surface functionalities was investigated. In addition, the sonocatalytic activities at various pH values, temperatures, pollutant concentrations, catalyst dosages, initial H2O2 concentrations, and organic matter contents were investigated. The experiments on the sonocatalytic elimination of SD and AAP revealed that MXe/MIL-101(Cr) exhibited a catalytic efficiency of âˆ¼ 98% in 80 min when the MXene loading was 30 wt% in the nanocomposite. Under optimized reaction conditions, the degradation efficiency of MXe/MIL-101(Cr) reached 91.5% for SD and 90.6% for AAP in 60 min; these values were 1.2 and 1.8 times greater than those of MXene and MIL-101(Cr), respectively. The high surface area of the MXe/MIL-101(Cr) nanocomposite increased from 4.68 m2/g to 294.21 m2/g, and the band gap of the tagged MIL-101(Cr) on the MXene surface was minimized. The superior sonocatalytic activity of MXe/MIL-101(Cr) was attributed to the effective contact interface, the effective separation rate of e- - h+ pairs through the type II heterostructure interface, and the favorable high free •OH radical production rates that promoted the degradation of SD and AAP. The solid heterointerface between MIL-101(Cr) and MXene was confirmed through Raman and FTIR analysis and was found to promote accessible •OH radical production under sonication, thus maximizing the catalytic activity of nanocomposites. The present results present an effective strategy for the design of a highly efficient, low-cost, reliable sonocatalyst that can eradicate pharmaceutical pollutants in our environment.

Carbon nanotube-wastewater treatment nexus: Where are we heading to?

Water treatment is crucial in solving the rising people's appetite for water and global water shortages. Carbon nanotubes (CNTs) have considerable promise for water treatment because of their adjustable and distinctive arbitrary, physical, as well as chemical characteristics. This illustrates the benefits and risks of integrating CNT into the traditional water treatment resource. Due to their outstanding adsorbent ability and chemical and mechanical properties, CNTs have gained global consideration in environmental applications. The desalination and extraction capability of CNT were improved due to chemical or physical modifications in pure CNTs by various functional groups. The CNT-based composites have many benefits, such as antifouling performance, high selectivity, and increased water permeability. Nevertheless, their full-scale implementations are still constrained by their high costs. Functionalized CNTs and their promising nanocomposites to eliminate contaminants are advised for marketing and extensive water/wastewater treatment.

Recent advances and future perspectives in the therapeutics of prostate cancer.

Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is at the highest risk of developing high-grade PC. It can be challenging to distinguish between low-risk and high-risk patients due to the slow progression of PC. Prostate-specific antigen (PSA) is a revolutionary discovery for the identification of PC. However, it has led to an increase in over diagnosis and over treatment of PC in the past few decades. Even if modifications are made to the standard PSA testing, the specificity has not been found to be significant. Our understanding of PC genetics and proteomics has improved due to advances in different fields. New serum, urine, and tissue biomarkers, such as PC antigen 3 (PCA3), have led to various new diagnostic tests, such as the prostate health index, 4K score, and PCA3. These tests significantly reduce the number of unnecessary and repeat biopsies performed. Chemotherapy, radiotherapy, and prostatectomy are standard treatment options. However, newer novel hormone therapy drugs with a better response have been identified. Androgen deprivation and hormonal therapy are evolving as new and better options for managing hormone-sensitive and castration-resistant PC. This review aimed to highlight and discuss epidemiology, various risk factors, and developments in PC diagnosis and treatment regimens.

Microplastics and biobased polymers to combat plastics waste.

Microplastics (MPs) have become the major global concern due to their adverse effects on the environment, human health, and hygiene. These complex molecules have numerous toxic impacts on human well-being. This review focuses on the methods for chemically quantifying and identifying MPs in real-time samples, as well as the detrimental effects resulting from exposure to them. Biopolymers offer promising solutions for reducing the environmental impact caused by persistent plastic pollution. The review also examines the significant progress achieved in the preparation and modification of various biobased polymers, including polylactic acid (PLA), poly(ε-caprolactone) (PCL), lignin-based polymers, poly-3-hydroxybutyrate (PHB), and poly(hydroxyalkanoates) (PHA), which hold promise for addressing the challenges associated with unplanned plastic waste disposal.

Deep eutectic solvents induced changes in the phase transition behavior of smart polymers: a sustainable future approach.

Deep eutectic solvents (DESs) are considered "green" and "sustainable" alternatives to conventional organic solvents and ionic liquids (ILs) due to their characteristic properties and relatively low costs. DESs are considered IL analogs and have attracted consideration as benign media formulations for the synthesis of novel polymers because they satisfy the principle of sustainability. Over the past few years, the use of DESs has resulted in novel pathways for the synthesis of novel materials, biomaterials, functional materials, and ionic soft materials. Furthermore, DESs have been widely applied in the science, industrial, engineering, and technological fields. On the other hand, stimulus-responsive (smart) polymers have been widely utilized in intelligent devices owing to their virtues of good processibility, stimuli and environmental sensitivity, responsivity, and so on. With the introduction of a DES into the smart polymeric matrices, their potential characteristics, biocompatibility, and flexibility endow the corresponding DES-based polymeric materials with intriguing properties, which in turn will broaden their applications in various domains of polymer science and material chemistry. Substantial research has been done in the fabrication of DES-based polymeric materials. Numerous studies have extensively investigated the effects of DESs on biomolecules such as proteins/enzymes and nucleic acids, whereas few have addressed the impact of DESs on the aggregation and phase transition behaviors of smart polymers. This review focuses on mechanistic insights, aggregation behavior, and interactions between smart polymers and DESs. Opportunities and future research perspectives in this blossoming arena are also discussed. It is hoped that this review will pave futuristic pathways for the design and development of advanced DES-based polymeric materials and biomaterials for various applications.

Layered hydrated-titanium-oxide-laden reduced graphene oxide composite as a high-performance negative electrode for selective extraction of Li via membrane capacitive deionization.

In this work, we initially prepared layered lithium titanate (Li2TiO3) using a solid-state reaction. Then Li+ of Li2TiO3 were acid-eluded with Hydrochloric acid to obtain hydrated titanium oxide (H2TiO3). Different weight percentages (50%, 60%, 70%, 80%, and 90%) of the as-prepared H2TiO3 were deposited on a conductive reduced graphene oxide (rGO) matrix to obtain a series of rGO/ H2TiO3 composites. Of the prepared composites, rGO/H2TiO3-60% showed excellent current density, high specific capacitance, and rapid ion diffusion. An asymmetric MCDI (membrane capacitive deionization) cell fabricated with activated carbon as the anode and rGO/H2TiO3-60% as the cathode displayed outstanding Li+ electrosorption capacity (13.67 mg g-1) with a mean removal rate of 0.40 mg g-1 min-1 in a 10 mM LiCl aqueous solution at 1.8 V. More importantly, the rGO/H2TiO3-60% composite electrode exhibited exceptional Li+ selectivity, superior cyclic stability up to 100,000 s, and a Li+ sorption capacity retention of 96.32% after 50 adsorption/desorption cycles. The excellent Li+ extraction obtained by MCDI using the rGO/H2TiO3-60% negative electrode was putatively attributed to: (i) ion exchange between Li+ and H+ of H2TiO3; (ii) the presence of narrow lattice spaces in H2TiO3 suitable for selective Li+ capture; (iii) capture of Li+ by isolated and hydrogen-bonded hydroxyl groups of H2TiO3; and (iv) enhanced interfacial contact and transfer of large numbers of Li+ ions from the electrolyte to H2TiO3 achieved by compositing H2TiO3 with a highly conductive rGO matrix.

Zn-ion Batteries: Charge Storing Mechanism and Development Challenges.

Improving the energy share of renewable energy technologies is the only solution to reduce greenhouse gas emissions and air pollution. The high-performing green battery energy storage technologies are critical for storing energy to address the intermittent nature of renewable energy resources. In recent years, aqueous batteries, particularly Zn-ion batteries (ZIBs), have achieved and shown great potential for stationary energy storage systems owing to their low cost and safer operation. However, the practical applications of the ZIBs have significantly been impeded due to the gap between the breakthroughs achieved in academic research and industrial developments. The present review discusses the ZIB's advantages, possibilities, and shortcomings for stationary energy storage systems. The Review begins with a brief introduction to the ZIBs and their charge storage mechanisms based on the structural properties of cathode materials. The scientific and technical challenges that obstruct the commercialization of the ZIBs are discussed in detail concerning their impact on accelerating the utilization of the ZIBs for real-life applications. The final section highlights the outlook on research in this flourishing field.

Multicomponent-Loaded Vesosomal Drug Carrier for Controlled and Sustained Compound Release.

Liposomes have been extensively adopted in drug delivery systems with clinically approved formulations. However, hurdles remain in terms of loading multiple components and precisely controlling their release. Herein, we report a vesosomal carrier composed of liposomes encapsulated inside the core of another liposome for the controlled and sustained release of multiple contents. The inner liposomes are made of lipids with different compositions and are co-encapsulated with a photosensitizer. Upon induction of reactive oxygen species (ROS), the contents of the liposomes are released, with each type of liposome displaying distinct kinetics due to the variance in lipid peroxidation for differential structural deformation. In vitro experiments demonstrated immediate content release from ROS-vulnerable liposomes, followed by sustained release from ROS-nonvulnerable liposomes. Moreover, the release trigger was validated at the organismal level using Caenorhabditis elegans. This study demonstrates a promising platform for more precisely controlling the release of multiple components.

Recent Progress in Functional Nanomaterials towards the Storage, Separation, and Removal of Tritium.

Tritium is a sustainable next-generation prime fuel for generating nuclear energy through fusion reactions to fulfill the increasing global energy demand. Owing to the scarcity-high demand tradeoff, tritium must be bred inside a fusion reactor to ensure sustainability and must therefore be separated from its isotopes (protium and deuterium) in pure form, stored safely, and supplied on demand. Existing multistage isotope separation technologies exhibit low separation efficiency and require intensive energy inputs and large capital investments. Furthermore, tritium-contaminated heavy water constitutes a major fraction of nuclear waste, and accidents like the one at Fukushima Daiichi leave behind thousands of tons of diluted tritiated water, whose removal is beneficial from an environmental point of view. In this review, the recent progress and main research trends in hydrogen isotope storage and separation by focusing on the use of metal hydride (e.g., intermetallic, and high-entropy alloys), porous (e.g., zeolites and metal organic frameworks (MOFs)), and 2-D layered (e.g., graphene, hexagonal boron nitride (h-BN), and MXenes) materials to separate and store tritium based on their diverse functionalities are discussed. Finally, the challenges and future directions for implementing tritium storage and separation are summarized in the reviewed materials.

Efficient lithium extraction using redox-active Prussian blue nanoparticles-anchored activated carbon intercalation electrodes via membrane capacitive deionization.

Global demand for lithium (Li) resources has dramatically increased due to the demand for clean energy, especially the large-scale usage of lithium-ion batteries in electric vehicles. Membrane capacitive deionization (MCDI) is an energy and cost-efficient electrochemical technology at the forefront of Li extraction from natural resources such as brine and seawater. In this study, we designed high-performance MCDI electrodes by compositing Li+ intercalation redox-active Prussian blue (PB) nanoparticles with highly conductive porous activated carbon (AC) matrix for the selective extraction of Li+. Herein, we prepared a series of PB-anchored AC composites (AC/PB) containing different percentages (20%, 40%, 60%, and 80%) of PB by weight (AC/PB-20%, AC/PB-40%, AC/PB-60%, and AC/PB-80%, respectively). The AC/PB-20% electrode with uniformly anchored PB nanoparticles over AC matrix enhanced the number of active sites for electrochemical reaction, promoted electron/ion transport paths, and facilitated abundant channels for the reversible insertion/de-insertion of Li+ by PB, which resulted in stronger current response, higher specific capacitance (159 F g-1), and reduced interfacial resistance for the transport of Li+ and electrons. An asymmetric MCDI cell assembled with AC/PB-20% as cathode and AC as anode (AC//AC-PB20%) displayed outstanding Li+ electrosorption capacity of 24.42 mg g-1 and a mean salt removal rate of 2.71 mg g min-1 in 5 mM LiCl aqueous solution at 1.4 V with high cyclic stability. After 50 electrosorption-desorption cycles, 95.11% of the initial electrosorption capacity was retained, reflecting its good electrochemical stability. The described strategy demonstrates the potential benefits of compositing intercalation pseudo capacitive redox material with Faradaic materials for the design of advanced MCDI electrodes for real-life Li+ extraction applications.

The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy.

Breast cancer (BC) is the second most fatal disease and is the prime cause of cancer allied female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated by transcription factors (TFs) like NF-κB. NF-κB is a pro-inflammatory TF that crucially alters the expressions of various genes associated with inflammation, cell progression, metastasis, and apoptosis and modulates a network of genes that underlie tumorigenesis. Herein, we focus on NF-κB signaling pathways, its regulators, and the rationale for targeting NF-κB. This review also includes TFs that maintain NF-κB crosstalk and their roles in promoting angiogenesis and metastasis. In addition, we discuss the importance of combination therapies, resistance to treatment, and potential novel therapeutic strategies including nanomedicine that targets NF-κB.

Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials.

Cancer is a major global public health concern that affects both industrialized and developing nations. Current cancer chemotherapeutic options are limited by side effects, but plant-derived alternatives and their derivatives offer the possibilities of enhanced treatment response and reduced side effects. A plethora of recently published articles have focused on treatments based on cannabinoids and cannabinoid analogs and reported that they positively affect healthy cell growth and reverse cancer-related abnormalities by targeting aberrant tumor microenvironments (TMEs), lowering tumorigenesis, preventing metastasis, and/or boosting the effectiveness of chemotherapy and radiotherapy. Furthermore, TME modulating systems are receiving much interest in the cancer immunotherapy field because it has been shown that TMEs have significant impacts on tumor progression, angiogenesis, invasion, migration, epithelial to mesenchymal transition, metastasis and development of drug resistance. Here, we have reviewed the effective role of cannabinoids, their analogs and cannabinoid nano formulations on the cellular components of TME (endothelial cells, pericytes, fibroblast and immune cells) and how efficiently it retards the progression of carcinogenesis is discussed. The article summarizes the existing research on the molecular mechanisms of cannabinoids regulation of the TME and finally highlights the human studies on cannabinoids' active interventional clinical trials. The conclusion outlines the need for future research involving clinical trials of cannabinoids to demonstrate their efficacy and activity as a treatment/prevention for various types of human malignancies.

Amelioration of Hepatotoxic and Neurotoxic Effect of Cartap by Aloe vera in Wistar Rats.

Pesticide exposure can pose a serious risk to nontarget animals. Cartap is being broadly used in agricultural fields. The toxic effects of cartap on the levels of hepatotoxicity and neurotoxicity have not been properly studied in mammalian systems. Therefore, the present work focused on the effect of cartap on the liver and brain of Wistar rats and made an assessment of the ameliorating potential of A. vera. The experimental animals were divided into 4 groups, comprising six rats in each: Group 1-Control; Group 2-A. vera; Group 3-Cartap; and Group 4-A. vera + Cartap. The animals orally given cartap and A. vera were sacrificed after 24 h of the final treatment and histological and biochemical investigations were conducted in liver and brain of Wistar rats. Cartap at sublethal concentrations caused substantial decreases in CAT, SOD, and GST levels in the experimental rats. The activity levels of transaminases and phosphatases in cartap group were also found to be substantially altered. The AChE activity was recorded as decreasing in RBC membrane and brain of the cartap-treated animals. The TNF-α and IL-6 level in serum were increased expressively in the cartap challenged groups. Histological investigation of liver showed disorganized hepatic cords and severely congested central veins due to cartap. However, the A. vera extract was observed to significantly protect against the effects of cartap toxicity. The protective impact of A. vera against cartap toxicity may be due to the existence of antioxidants in it. These findings suggest that A. vera may be developed as a potential supplement to the appropriate medication in the treatment of cartap toxicity.

HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer.

HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose expression is strongly correlated with the tumor grade and prognosis of a variety of carcinomas including breast cancer (BC). HOTAIR regulates various target genes via sponging and epigenetic mechanisms and controls various oncogenic cellular and signaling mechanisms including metastasis and drug resistance. In BC cells, HOTAIR expression is regulated by a variety of transcriptional and epigenetic mechanisms. In this review, we describe the regulatory mechanisms that govern HOTAIR expression during cancer development and explore how HOTAIR drives BC development, metastasis, and drug resistance. In the final section of this review, we focus on the role of HOTAIR in BC management, therapeutic treatment, and prognosis, highlighting its potential therapeutic applications.

Harnessing protein sensing ability of electrochemical biosensors via a controlled peptide receptor-electrode interface.

BACKGROUND: Cathepsin B, a cysteine protease, is considered a potential biomarker for early diagnosis of cancer and inflammatory bowel diseases. Therefore, more feasible and effective diagnostic method may be beneficial for monitoring of cancer or related diseases. RESULTS: A phage-display library was biopanned against biotinylated cathepsin B to identify a high-affinity peptide with the sequence WDMWPSMDWKAE. The identified peptide-displaying phage clones and phage-free synthetic peptides were characterized using enzyme-linked immunosorbent assays (ELISAs) and electrochemical analyses (impedance spectroscopy, cyclic voltammetry, and square wave voltammetry). Feasibilities of phage-on-a-sensor, peptide-on-a-sensor, and peptide-on-a-AuNPs/MXene sensor were evaluated. The limit of detection and binding affinity values of the peptide-on-a-AuNPs/MXene sensor interface were two to four times lower than those of the two other sensors, indicating that the peptide-on-a-AuNPs/MXene sensor is more specific for cathepsin B (good recovery (86-102%) and %RSD (< 11%) with clinical samples, and can distinguish different stages of Crohn's disease. Furthermore, the concentration of cathepsin B measured by our sensor showed a good correlation with those estimated by the commercially available ELISA kit. CONCLUSION: In summary, screening and rational design of high-affinity peptides specific to cathepsin B for developing peptide-based electrochemical biosensors is reported for the first time. This study could promote the development of alternative antibody-free detection methods for clinical assays to test inflammatory bowel disease and other diseases.